TRAF3IP2 antibody (Internal Region)
-
- Target See all TRAF3IP2 Antibodies
- TRAF3IP2 (TRAF3 Interacting Protein 2 (TRAF3IP2))
-
Binding Specificity
- Internal Region
-
Reactivity
- Human
-
Host
- Goat
-
Clonality
- Polyclonal
-
Conjugate
- This TRAF3IP2 antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA
- Purpose
- TRAF3IP2
- Sequence
- PDTGHDSDKS DQ
- Specificity
- This antibody is expected to recognise reported isoforms 2 and 3 (NP_679211.1, NP_001157753.1).
- Cross-Reactivity
- Human, Mouse, Rat
- Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Grade
- Verified
- Isotype
- IgG
- Top Product
- Discover our top product TRAF3IP2 Primary Antibody
-
-
- Application Notes
-
Western Blot: Approx 65 kDa band observed in lysates of cell line MCF7 (calculated MW of 63.6 kDa according to NP_679211.1). Recommended concentration: 1-3 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:2000.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Minimize freezing and thawing.
- Storage
- -20 °C
- Storage Comment
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
- Target
- TRAF3IP2 (TRAF3 Interacting Protein 2 (TRAF3IP2))
- Alternative Name
- TRAF3IP2 (TRAF3IP2 Products)
- Background
- TRAF3IP2, TRAF3 interacting protein 2 , ACT1, C6orf4, C6orf5, C6orf6, CIKS, DKFZP586G0522, MGC3581, NFkB-activating protein ACT1, OTTHUMP00000040422, connection to IKK and SAPK/JNK
- Gene ID
- 10758
- NCBI Accession
- NP_679211, NP_001157753
- Pathways
- Production of Molecular Mediator of Immune Response
-